DOCSLIB.ORG

Muir-Torre Syndrome: a Case Report and Review of Screening Recommendations

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Muir-Torre Syndrome: a Case Report and Review of Screening Recommendations Volume 29 JAOCDJournal Of The American Osteopathic College Of Dermatology Muir-Torre Syndrome: A Case Report and Review of Screening Recommendations Also in this issue: Palisaded Neutrophilic and Granulomatous Dermatitis Keloidal Variant of Atypical Fibroxanthoma Benign Migratory Glossitis in a Patient with X-linked Ichthyosis last modified on October 1, 2014 4:16 PM JOURNAL OF THE AMERICAN OSTEOPATHIC COLLEGE OF DERMATOLOGY Page 1 JOURNAL OF THE AMERICAN OSTEOPATHIC COLLEGE OF DERMATOLOGY 2013-2014 AOCD OFFICERS PRESIDENT Suzanne Sirota-Rozenberg, DO, FAOCD PRESIDENT-ELECT Rick Lin, DO, FAOCD FIRST VICE-PRESIDENT Alpesh Desai, DO, FAOCD SECOND VICE-PRESIDENT Karthik Krishnamurthy, DO, FAOCD THIRD VICE-PRESIDENT Daniel Ladd, DO, FAOCD Editor-in-Chief SECRETARY-TREASURER Karthik Krishnamurthy, DO Jere J. Mammino, DO, FAOCD TRUSTEES John P. Minni, DO, FAOCD Bryan Sands, DO, FAOCD Danica Alexander, DO, FAOCD Reagan Anderson, DO, FAOCD Sponsors: Michael Whitworth, DO, FAOCD Tracy Favreau, DO, FAOCD Bayer Immediate Past-President AuroraDx David L. Grice, DO, FAOCD EEC Representatives Ranbaxy James Bernard, DO, FAOCD Michael Scott, DO, FAOCD Valeant Finance Committee Representative Steven K. Grekin, DO, FAOCD AOBD Representative Stephen Purcell, DO, FAOCD Executive Director Marsha A. Wise, BS 800-449-2623 • FAX: 660-627-2623 • www.aocd.org COPYRIGHT AND PERMISSION: Written permission must be obtained from the Journal of the American Osteopathic College of Dermatology for copying or reprinting text of more than half a page, tables or figures. Permissions are normally granted contingent upon similar permission from the author(s), inclusion of acknowledgement of the original source, and a payment of $15 per page, table or figure of reproduced material. Permission fees are waived for authors wishing to reproduce their own articles. Request for permission should be directed to JAOCD c/o AOCD, PO Box 7525, Kirksville, MO 63501. Copyright © 2003 by the Journal of the American Osteopathic College of Dermatology Print by: S&S Printing and Graphics LLC, 401 N. Marion St., Kirksville, MO 63501 Copy editing by: Julia Layton, Freelance Writing and Editing Layout and cover design by: TJ Mahlin Cover images provided by Bijal Amin, MD (Bronx, NY) Page 2 JOURNAL OF THE AMERICAN OSTEOPATHIC COLLEGE OF DERMATOLOGY TABLE OF CONTENTS Volume 29 JAOCD Editors ............................................................................................................................................................................................ 4 Letter from the Editor-in-Chief ................................................................................................................................................................... 5 Letter from the Executive Director ............................................................................................................................................................... 6 Letter from the President .............................................................................................................................................................................. 7 FEATURE ARTICLE: Muir-Torre Syndrome: A Case Report and Review of Screening Recommendations Nicholas A. Rudloff, DO, Natalie J. Steinhoff, BS, Schield M. Wikas, DO, FAOCD, Joshua A. Weaver, MD.........................................................12 EDITOR’S PICKS: Palisaded Neutrophilic and Granulomatous Dermatitis: A Case Presentation and Discussion Julie Frederickson, DO, Stanley Skopit, DO, MSE, FAOCD .......................................................................................................................15 Keloidal Variant of Atypical Fibroxanthoma: A Case Report and Review of the Literature Emily Kate Matthews, DO, Robin Shecter, DO, John Howard, BS ............................................................................................................18 Benign Migratory Glossitis in a Patient with X-linked Ichthyosis: A Case Report and Review of the Literature Emily Kollmann DO, Brooke Walls, DO, Richard Miller, DO ....................................................................................................................20 ORIGINAL ARTICLES AND CASE REPORTS Polymorphous Light Eruption in a 50-year-old Female on Bilateral Extensor Surfaces of the Upper Extremities Mayha Patel, DO, Michael Kassardjian, DO, David Horowitz, DO, FAOCD, Paul Shitabata, MD ..........................................................22 Elephantiasis Nostras Verrucosa Jeffrey Collins, BS, Michelle Duff, DO, Jason Barr, DO, Richard L. Averitte Jr., MD, Christine C. Lin, MD .............................................26 Unilesional Folliculotropic Mycosis Fungoides Lacey Beth Elwyn, DO, Jenifer R. Lloyd, DO, Kenneth M. Lloyd, MD .....................................................................................................29 Perspective: Treatment of Rhinophyma with Electrosurgery, a Possibly Underutilized Technique Jonathan S Crane, DO, FAOCD, J. Kate Jackson, PA-C, Joseph Annunziata, MD, Kirsten Schneider, PA-C ...............................................31 Atypical Presentation of a Granular Cell Tumor: A Case Report and Review of the Literature Alexander Dane, DO, Jesse Jensen, DO, John Pui, MD, Annette LaCasse, DO ...........................................................................................33 A Case of Idiopathic Atrophoderma of Pasini and Pierini Brittany E. Grady, DO, Jenifer R. Lloyd, DO ...............................................................................................................................................36 Cutaneous Metastasis of Gastrointestinal Stromal Tumor (GIST): A Case Presentation and Discussion Brett K. Matheson, MD, Shannon P. Buck, DO .........................................................................................................................................38 A Case of Tattoo-Related Keratoacanthomas Samuel M. Wilson, DO, Paul M. Graham, DO, Daniel S. Hurd, DO, FAOCD ..........................................................................................41 A Rare Case of Acquired Epidermodysplasia Verruciformis Steven Brooks, DO, Evelyn Gordon, DO, Suzanne Sirota Rozenberg, DO, FAOCD ...................................................................................44 An Atypical Presentation of Lichen Sclerosus et Atrophicus: Guttate Lesions Presenting in Bilateral Axillae and Inguinal Regions Mayha Patel, DO, Teresa Ishak, DO, David Horowitz, DO, FAOCD .......................................................................................................47 Pseudochromhidrosis: A Case of Blue-Green Facial and Hand Discoloration Sarah Belden, BA, G. Trey Haunson, DO, MS, Daniel Hurd, DO, FAOCD ......................................................................................................................50 JOURNAL OF THE AMERICAN OSTEOPATHIC COLLEGE OF DERMATOLOGY Page 3 Editor-In-Chief Founding Editor Assistant Editor Karthik Krishnamurthy, DO Jay Gottleib, DO Julia Layton, BA, MFA Associate Editors Derrick Adams, DO Aaron Bruce, DO Michelle Foley, DO Michael Scott, DO Scott Wickless, DO Red Bluff, CA Bozeman, Montana Ormond Beach, FL Seattle, WA Dallas, Texas Editorial Board Sami Abbasi, DO Brad Glick, DO Angela Leo, DO John Perrotto, DO Brownstown, MI Margate, FL New York, NY West Palm Beach, FL Brad Abrams, DO Marcus Goodman, DO Scott Lim, DO Stephen Purcell, DO Sarasota, FL Roswell, GA Erie, PA Allentown, PA Andrew Racette, DO Kevin Belasco, DO Melinda Greenfield, DO Chava Lustig, DO Phoenix, AZ Milwaukee, WI Albany. GA Weston, FL Brett Bender, DO Denise Guevara, DO Jere Mammino, DO Richard Rudnicki, DO Farmington Hills, MI Weston, FL Winter Springs, FL Mesquite, TX Ryan Carlson, DO Andrew Hanly, MD Chris Manlio, DO Amara Sayed, DO Hilliard, OH Miami, FL Loxahatchee, FL San Marcos, TX Igor Chaplik, DO Joel Harris, DO John Minni, DO Joseph Brant Schneider, DO Aventura, FL Madison Heights, MI Port St. Lucie, FL Shawnee Mission, KS Tony Nakhla, DO Gregg Severs, DO Michael P. Conroy, MD Heather Higgins, DO Orange County, CA Scranton, PA Columbus, OH Troy, MI Matthew Elias, DO David Horowitz, DO Navid Nami, DO Sean Stephenson, DO Lighthouse Point, FL Torrence, CA Newport Beach, CA Troy, MI Jacqueline Thomas, DO Merrick Elias, DO Matt Leavitt, DO Jon Keeling, DO Fort Lauderdale, FL Delray Beach, FL Maitland, FL Lexington, KY Adam Friedman, MD Mark Lebwohl, MD Dimitria Papadopoulos, DO Jim Towry, DO Bronx, NY New York, NY Bellmore, NY Ocala, FL Page 4 JAOCD EDITORS LETTER FROM THE EDITOR-IN-CHIEF Karthik Krishnamurthy, DO, FAOCD Editor-in-Chief Dear Members, It is with great pleasure that I announce that our Journal now qualifies for AOA CME credit! Over the last year, I submitted proposals to the AOA Committee for Continuing Medical Education (CCME). This April, the CCME approved reading of the Journal for 6 credits during a three-year cycle, under Category 2-B. At the back of this volume, you will find a tear-away form that only needs to be submitted once (at the end of each cycle) for these CME credits. The form is also available on the AOCD web site (www.AOCD.org). I am also proud of the enthusiasm of our Editorial Board. We have recruited more reviewers. Derrick Adams, DO, has been promoted to Associate Editor. The Associate Editors have tremendous responsibility and workload. Please thank all of our Editors and Reviewers for their service whenever you see them. The next step, should we choose to pursue it, would be qualification
Load more

Recommended publications
  • Rare Skin Cancers in General Practice
    CLINICAL PRACTICE Skin cancer Rare skin cancers in series general practice Case study Anthony Dixon Mr LA has long been troubled with actinic damage to his skin, especially his face. He has had MBBS, FACRRM, is many squamous cell carcinomas (SCCs) removed and many solar keratoses managed. dermasurgeon and Director On this occasion Mr LA had two actinic lesions on his left cheek that failed to respond to of Research, Skin Alert cryotherapy (Figure 1). A biopsy of each site produced a surprise. Histology of the superior Skin Cancer Clinics and lesion revealed sebaceous carcinoma (Figure 2). This is an uncommon yet aggressive cutaneous Skincanceronly, Belmont, malignancy derived from sebaceous glands. The 5 year survival rate is 60–70%. Victoria. anthony@ The tumour was widely excised with a minimum 10 mm margin. A multidisciplinary approach skincanceronly.com resulted in a decision not to proceed to adjunctive radiotherapy. The wound was well healed by 8 weeks (Figure 3). Four years on there is no sign of local or regional recurrence (Figure 4). Many sebaceous carcinomas occur on the eyelids where the outcome is often poor;1 and some patients are prone to multiple other cutaneous SCCs. There is also a rare syndrome called Muir-torre of visceral neoplasms associated with sebaceous carcinoma on the skin.2 As this is an autosomal dominant condition, family history and counselling is an esssential part of management (enquire about family history of internal malignancies). A family member's diagnosis can be Figure 3. Satisfactory healing 8 weeks Figure 1. Two actinic lesions on the left face following wide excision of sebaceous important for other family members and offers screening have failed to respond to cryotherapy carcinoma for internal and cutaneous malignancies.
    [Show full text]
  • Atypical Compound Nevus Arising in Mature Cystic Ovarian Teratoma
    J Cutan Pathol 2005: 32: 71–123 Copyright # Blackwell Munksgaard 2005 Blackwell Munksgaard. Printed in Denmark Journal of Cutaneous Pathology Abstracts of the Papers Presented at the 41st Annual Meeting of The American Society of Dermatopathology Westin Copley Place Boston, Massachusetts, USA October 14–17, 2004 These abstracts were presented in oral or poster format at the 41st Annual Meeting of The American Society of Dermatopathology on October 14–17, 2004. They are listed on the following pages in alphabetical order by the first author’s last name. 71 Abstracts IN SITU HYBRIDIZATION IS A VALUABLE DIAGNOSTIC A 37-year-old woman with diagnosis of Sjogren’s syndrome (SS) TOOL IN CUTANEOUS DEEP FUNGAL INFECTIONS presented with asymptomatic non-palpable purpura of the lower J.J. Abbott1, K.L. Hamacher2,A.G.Bridges2 and I. Ahmed1,2 extremities. Biopsy of a purpuric macule revealed a perivascular Departments of Laboratory Medicine and Pathology1 and and focally nodular lymphocytic infiltrate with large numbers of Dermatology2, plasma cells, seemingly around eccrine glands. There was no vascu- litis. The histologic findings in the skin were strikingly similar to those Mayo Clinic and Mayo Foundation, Rochester, MN, USA of salivary, parotid, and other ‘‘secretory’’ glands affected in SS. The cutaneous manifestations of SS highlighted in textbooks include Dimorphic fungal infections (histoplasmosis, blastomycosis, coccidiomy- xerosis, annular erythema, small-vessel vasculitis, and pigmented cosis, and cryptococcosis) can occur in immunocompromised and purpura. This case illustrates that purpura in skin of patients with healthy individuals. Cutaneous involvement is often secondary and SS may be caused by a peri-eccrine plasma-rich infiltrate.
    [Show full text]
  • Atypical Fibroxanthoma - Histological Diagnosis, Immunohistochemical Markers and Concepts of Therapy
    ANTICANCER RESEARCH 35: 5717-5736 (2015) Review Atypical Fibroxanthoma - Histological Diagnosis, Immunohistochemical Markers and Concepts of Therapy MICHAEL KOCH1, ANNE J. FREUNDL2, ABBAS AGAIMY3, FRANKLIN KIESEWETTER2, JULIAN KÜNZEL4, IWONA CICHA1* and CHRISTOPH ALEXIOU1* 1Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Erlangen, Erlangen, Germany; 2Dermatology Clinic, 3Institute of Pathology, and 4ENT Department, University Hospital Mainz, Mainz, Germany Abstract. Background: Atypical fibroxanthoma (AFX) is an in 1962 (2). The name 'atypical fibroxanthoma' reflects the uncommon, rapidly growing cutaneous neoplasm of uncertain tumor composition, containing mainly xanthomatous-looking histogenesis. Thus far, there are no guidelines for diagnosis and cells and a varying proportion of fibrocytoid cells with therapy of this tumor. Patients and Methods: We included 18 variable, but usually marked cellular atypia (3). patients with 21 AFX, and 2,912 patients with a total of 2,939 According to previous reports, AFX chiefly occurs in the AFX cited in the literature between 1962 and 2014. Results: In sun-exposed head-and-neck area, especially in elderly males our cohort, excision with safety margin was performed in 100% (3). There are two disease peaks described: one within the 5th of primary tumors. Local recurrences were observed in 25% of to 7th decade of life and another one between the 7th and 8th primary tumors and parotid metastases in 5%. Ten-year disease- decade. The former disease peak is associated with lower specific survival was 100%. The literature research yielded 280 tumor frequency (21.8%) and tumors that do not necessarily relevant publications. Over 90% of the reported cases were manifest on skin areas exposed to sunlight (4).
    [Show full text]
  • Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma - Two Stages of the Same Disease?
    Case Report World Journal of Oral and Maxillofacial Surgery Published: 12 Jul, 2018 Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma - Two Stages of the Same Disease? Farhana Kapasi1*, Marta Cabral2, Phillip Ameerally1 and Antonia Barbieri1 1Department of Oral and Maxillofacial Surgery, Northampton General Hospital, UK 2Marta Cabral, The Royal Devon and Exeter NHS Foundation Trust, UK Abstract Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma are rare cutaneous neoplasm's which share clinical and Histopathological features which can pose a diagnostic challenge. Atypical Fibroxanthoma has been considered a low-grade malignancy whereas Pleomorphic Dermal Sarcoma has been considered high grade and aggressive. We report a case of an 83-year-old male with a history of Actinic Keratosis who presented with an erythematous papule on the right parietal scalp. Histopathological diagnosis was Atypical Fibroxanthoma. Seven months postoperatively, the patient developed a rapidly growing purple nodule at the operative site which was adherent to the skull. Histopathological diagnosis was Pleomorphic Dermal Sarcoma with bone involvement. We suggest that the recurrence rate and low aggressive potential of Atypical Fibroxanthoma may have been underestimated, as these tumours are rare and have not been widely reported in the literature. In this case, the tumour recurred following complete excision. The recurrence was the more infiltrative Pleomorphic Dermal Sarcoma, which reinforces the hypotheses that Atypical Fibroxanthoma may be the precursor lesion of Pleomorphic Dermal Sarcoma and that these are indeed two stages of the same disease rather than separate entities. Keywords: General dermatology; Medical dermatology; Head and neck oncology Introduction OPEN ACCESS Atypical Fibroxanthoma is a rare cutaneous tumour first described in 1963 by Elson Helwig [1].
    [Show full text]
  • Cutaneous Neoplasms
    torr CALIFORNIA TUMOR TISSUE REGISTRY 1 03RD SEMI-ANNUAL CANCER SEMINAR ON CUTANEOUS NEOPLASMS CASE HISTORIES 00•MODERAT.0RS: . PHILIP E. LE~0FJ', M.Q. Dir;ector O:f Oermatopafholo.gy ;Ser:Vice Associate Professor of Clinical Pathology U.C.S.F.- Elermatopa~hology San Francisco, ·californla and TIMGTH1f' H. MCG~WMON'f,, M ~D. Assistant Clinical Professor U.C~S.F. - Dermatopathology San Francisco, California December 7, 1997 Sheraton Palace Hotel San Francisco, California PLATFORM CHAIR: CLAUDE 0. BURDICK, M.D. Director of laboratory ValleyCare Health System Pleasanton, California CASE RISTORJES 10.3"" Semi-Annual Seminar (Due to in$uffient material, Case 115 is • compo~ite to two ca!ICll with an identical diagnosis, Ace. #15523 and Ace #12395.) Ca.c 1#1 - As:c 1#28070: The patient was a 12-ycaro{)ld male who had a fairly long history ofa very small bump in the scalp of the temporal area, which had recently become greally enlarged. The submitting denna!ologist mentioned that this was a soliwy lesion, with no other lesions apparent (Contributed by Prescott Rasmussen, MD.) c-111- As:c #11543: The patient was a 60-year-old Caucasian female wbo presented with a S.O em right suprapalellar subcutaneous mass which was reported to be present and gradually increasing in size for a period of approximately rn·o years. There was no history of prior trauma, and the remainder ofthe clinical history and physical findings wcze uoremarialble. An cxeisional biopsy was performed. The specimeD consisted ofa 4.S x 1.1 em elliptical segment ofeentnllly dimpled skin which surmowlted a S.3 x 4.4 x 3.6 em delicately encapsulated.
    [Show full text]
  • Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review
    toxins Review Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review Emanuela Martina †, Federico Diotallevi †, Giulia Radi †, Anna Campanati * and Annamaria Offidani Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, 60020 Ancona, Italy; [email protected] (E.M.); [email protected] (F.D.); [email protected] (G.R.); annamaria.offi[email protected] (A.O.) * Correspondence: [email protected] † These authors equally contributed to the manuscript. Abstract: Botulinum toxin is a superfamily of neurotoxins produced by the bacterium Clostridium Botulinum with well-established efficacy and safety profile in focal idiopathic hyperhidrosis. Recently, botulinum toxins have also been used in many other skin diseases, in off label regimen. The objective of this manuscript is to review and analyze the main therapeutic applications of botulinum toxins in skin diseases. A systematic review of the published data was conducted, following Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Botulinum toxins present several label and off-label indications of interest for dermatologists. The best-reported evidence concerns focal idiopathic hyperhidrosis, Raynaud phenomenon, suppurative hidradenitis, Hailey–Hailey disease, epidermolysis bullosa simplex Weber–Cockayne type, Darier’s disease, pachyonychia congenita, aquagenic keratoderma, alopecia, psoriasis, notalgia paresthetica, facial erythema and flushing, and oily skin.
    [Show full text]
  • Myxofibrosarcoma Mimicking Inflammatory Lesion Of
    applied sciences Communication Myxofibrosarcoma Mimicking Inflammatory Lesion of Temporomandibular Joint—Case Presentation Dawid Zagacki 1,*, Krzysztof Sztychny 2, Marta Tyndorf 2, Robert Bibik 3, Dominik Sygut 4 and Marcin Kozakiewicz 2 1 International Doctoral School, Medical University of Łód´z,Pl. Hallera 1, 90-647 Łód´z,Poland 2 Department of Maxillofacial Surgery, Medical University of Łód´z,Pl. Hallera 1, 90-647 Łód´z,Poland; [email protected] (K.S.); [email protected] (M.T.); [email protected] (M.K.) 3 Department of Radiation Oncology, Radom’s Oncology Centre, 26-600 Radom, Poland; [email protected] 4 Department of Clinical Patomorphology and Cytopathology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland; [email protected] * Correspondence: [email protected] Abstract: Treating oncologic patients remains a challenge for surgeons aiming to provide patients with safe margins of resection while maintaining the highest possible quality of life. The latter, in the case of malignancies, requires using sophisticated methods of reconstruction. Thus, we present a case of a 75-year-old patient treated in our department with a rare neoplasm in the region of the temporomandibular joint—a myxofibrosarcoma that was mimicking an inflammatory lesion. The patient underwent two surgeries—firstly alloplasty of the TMJ due to the suspicion of an inflammatory lesion, lately extended to the resection of glenoid fossa and subtemporal fossa contents when the mandible was reconstructed using UHMW-PE (ultra-high molecular weight polyethylene). Citation: Zagacki, D.; Sztychny, K.; The patient was also referred for adjuvant radiotherapy and has remained disease-free for over Tyndorf, M.; Bibik, R.; Sygut, D.; 96 months with very good aesthetics and function of the mandible.
    [Show full text]
  • The 2020 WHO Classification of Soft Tissue Tumours: News and Perspectives
    PATHOLOGICA 2021;113:70-84; DOI: 10.32074/1591-951X-213 Review The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives Marta Sbaraglia1, Elena Bellan1, Angelo P. Dei Tos1,2 1 Department of Pathology, Azienda Ospedale Università Padova, Padova, Italy; 2 Department of Medicine, University of Padua School of Medicine, Padua, Italy Summary Mesenchymal tumours represent one of the most challenging field of diagnostic pathol- ogy and refinement of classification schemes plays a key role in improving the quality of pathologic diagnosis and, as a consequence, of therapeutic options. The recent publica- tion of the new WHO classification of Soft Tissue Tumours and Bone represents a major step toward improved standardization of diagnosis. Importantly, the 2020 WHO classi- fication has been opened to expert clinicians that have further contributed to underline the key value of pathologic diagnosis as a rationale for proper treatment. Several rel- evant advances have been introduced. In the attempt to improve the prediction of clinical behaviour of solitary fibrous tumour, a risk assessment scheme has been implemented. NTRK-rearranged soft tissue tumours are now listed as an “emerging entity” also in con- sideration of the recent therapeutic developments in terms of NTRK inhibition. This deci- sion has been source of a passionate debate regarding the definition of “tumour entity” as well as the consequences of a “pathology agnostic” approach to precision oncology. In consideration of their distinct clinicopathologic features, undifferentiated round cell sarcomas are now kept separate from Ewing sarcoma and subclassified, according to the underlying gene rearrangements, into three main subgroups (CIC, BCLR and not Received: October 14, 2020 ETS fused sarcomas) Importantly, In order to avoid potential confusion, tumour entities Accepted: October 19, 2020 such as gastrointestinal stroma tumours are addressed homogenously across the dif- Published online: November 3, 2020 ferent WHO fascicles.
    [Show full text]
  • Expert-Level Diagnosis of Nonpigmented Skin Cancer by Combined Convolutional Neural Networks
    Supplementary Online Content Tschandl P, Rosendahl C, Akay BN, et al. Expert-level diagnosis of nonpigmented skin cancer by combined convolutional neural networks. JAMA Dermatol. Published online November 28, 2018. doi:10.1001/jamadermatol.2018.4378 eFigure. Sensitivities (Blue) and Specificities (Orange) at Different Threshold Cutoffs (Green) of the Combined Classifier Evaluated on the Validation Set eAppendix. Neural Network Training eTable 1. Complete List of Diagnoses and Their Frequencies Within the Test-Set eTable 2. Education of Users According to Their Experience Group eTable 3. Percent of Correct Prediction of the Malignancy Status for Specific Diagnoses of a CNN Using Either Close-up or Dermatoscopic Images This supplementary material has been provided by the authors to give readers additional information about their work. © 2018 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/25/2021 eFigure. Sensitivities (Blue) and Specificities (Orange) at Different Threshold Cutoffs (Green) of the Combined Classifier Evaluated on the Validation Set A threshold cut at 0.2 (black) is found for a minimum of 51.3% specificity. © 2018 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/25/2021 eAppendix. Neural Network Training We compared multiple architecture and training hyperparameter combinations in a grid-search fashion, and used only the single best performing network for dermoscopic and close-up images, based on validation accuracy, for further analyses. We trained four different CNN architectures (InceptionResNetV2, InceptionV3, Xception, ResNet50) and used model definitions and ImageNet pretrained weights as available in the Tensorflow (version 1.3.0)/ Keras (version 2.0.8) frameworks.
    [Show full text]
  • Shared Data & Cancer Registries
    15 4 2021 Shared data & Cancer registries Jean-Yves BLAY Prof. of Medical oncology Director of Centre Léon Bérard Director of the ERN-EURACAN French Academy of Medicine President of Unicancer Disclosures Company Scientific advice Scientific works Symposia & oral communications Abbvie X X Amgen X X X ARIAD X X AstraZeneca X X Bayer X X X BMS X X X Deciphera x x DDB X X EISAI X X X Genomic Health X X Gilead X X GSK X X INNATE PHARMA X (member of the Supervisory committee) INCYTE X IQVIA x x x Jansenn X X LILLY X X Merck Serono X X MSD X X Nanobiotix X x Novartis X X X Novex X X Onxeo X Pfizer X X Pharmamar X X PRA X Roche X X Sanofi Aventis X X Swedish Orphan X X Takeda X Toray X Shared data & Cancer registries • The revolution of oncology : precision medicine vs biology based oncology (.. emerging rare cancers) • Shared data & registries: • Diagnosis • Epidemiology • Optimal primary treatment is cheaper • Connecting patients and doctors • Academic clinical and translational research Nosology and treatment Histology Nosology & treatment 2021+ Trials on molecular/immune Histology subgroups Molecular Trials on somatic genotype? Stroma characterization SHIVA, SAFIR, MOST (immune cells…) BASKET ! Example : NTRK fusions across cancers 0.5-1% of all cancers 9000/year in EU? Diagnosis? Treatment? EURACAN : THE ERN FOR RARE ADULT SOLID CANCERS Sub-thematic areas Connective tissue Female genital organs and placenta Male genital organs, and of the urinary tract Neuroendocrine system Digestive tract Endocrine organs 20% of cancers Head and neck 30%
    [Show full text]
  • Diagnostic Value of CD163 in Cutaneous Spindle Cell Lesions
    J Cutan Pathol 2009: 36: 859–864 Copyright # 2008 John Wiley & Sons A/S doi: 10.1111/j.1600-0560.2008.01179.x John Wiley & Sons. Printed in Singapore Journal of Cutaneous Pathology Continuing Medical Education Article Diagnostic value of CD163 in cutaneous spindle cell lesions Background: The histologic diagnosis of atypical fibroxanthoma Pedram Pouryazdanparast1, (AFX) can sometimes be challenging. No specific marker exists to Limin Yu1, Jonathan E. Cutlan1, confirm the diagnosis other than excluding other entities. CD163 has Stephen H. Olsen1,2, Douglas been shown to have great specificity for tumors of monocyte/histiocyte R. Fullen1,2 and Linglei Ma1,2 lineage. In this study, we evaluated the diagnostic utility of CD163 in 1Department of Pathology and diagnosing AFX and in identifying skin lesions with histiocytic/ 2Department of Dermatology, University of dendritic derivation. Michigan, Ann Arbor, MI, USA Methods: A total of 157 cases, including 14 AFXs, 5 spindle cell squamous cell carcinomas (SCCs), and 7 spindle cell/desmoplastic melanomas, along with other cutaneous spindle cell and histiocytic/ fibrohistiocytic lesions, were stained with CD163. Results: CD163 was expressed in 11 of 14 (79%) AFXs, with moderate to strong intensity. No staining was observed in cases of spindle cell SCC (0/5) and dermatofibrosarcoma protuberans (0/10). Rare spindle cell/desmoplastic melanomas (2/7) and cutaneous leiomyosarcomas (1/5) demonstrated positive staining. CD163 reactivity was seen in 24 of 29 of benign fibrous histiocytomas (BFHs), including 8 of 8 celular fibrous histiocytomas and 6 of 9 epithelioid cell histiocytomas. The majority of cutaneous histiocytic lesions, including juvenile xanthogranuloma, Langerhans cell histiocytosis and Rosai– Dorfman disease, were positive for CD163.
    [Show full text]
  • XI. COMPLICATIONS of PREGNANCY, Childbffith and the PUERPERIUM 630 Hydatidiform Mole Trophoblastic Disease NOS Vesicular Mole Ex
    XI. COMPLICATIONS OF PREGNANCY, CHILDBffiTH AND THE PUERPERIUM PREGNANCY WITH ABORTIVE OUTCOME (630-639) 630 Hydatidiform mole Trophoblastic disease NOS Vesicular mole Excludes: chorionepithelioma (181) 631 Other abnormal product of conception Blighted ovum Mole: NOS carneous fleshy Excludes: with mention of conditions in 630 (630) 632 Missed abortion Early fetal death with retention of dead fetus Retained products of conception, not following spontaneous or induced abortion or delivery Excludes: failed induced abortion (638) missed delivery (656.4) with abnormal product of conception (630, 631) 633 Ectopic pregnancy Includes: ruptured ectopic pregnancy 633.0 Abdominal pregnancy 633.1 Tubalpregnancy Fallopian pregnancy Rupture of (fallopian) tube due to pregnancy Tubal abortion 633.2 Ovarian pregnancy 633.8 Other ectopic pregnancy Pregnancy: Pregnancy: cervical intraligamentous combined mesometric cornual mural - 355- 356 TABULAR LIST 633.9 Unspecified The following fourth-digit subdivisions are for use with categories 634-638: .0 Complicated by genital tract and pelvic infection [any condition listed in 639.0] .1 Complicated by delayed or excessive haemorrhage [any condition listed in 639.1] .2 Complicated by damage to pelvic organs and tissues [any condi- tion listed in 639.2] .3 Complicated by renal failure [any condition listed in 639.3] .4 Complicated by metabolic disorder [any condition listed in 639.4] .5 Complicated by shock [any condition listed in 639.5] .6 Complicated by embolism [any condition listed in 639.6] .7 With other
    [Show full text]